Sort
10,766 grants matching “checkpoint inhibitor”
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
$389,162Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Double-Strand Break Sensing, Signaling, and Repair
$389,097John A Tainer · University Of Calif-Lawrenc Berkeley Lab · P01 · FY2013 · CA
Novobiocin-mediated polymerase theta inhibition in homologous recombination repair-deficient cancers
$389,092Geoffrey I Shapiro · Dana-Farber Cancer Inst · R01 · FY2023 · CA
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
$389,055Elad Ziv · University Of California, San Francisco · R01 · FY2020 · CA
MMS22L loss and PARP inhibition in prostate cancer
$388,990Li Jia · Brigham And Women'S Hospital · R01 · FY2024 · CA
Cell Cycle Checkpoint in Response to DNA Damage
$388,912Nancy C Walworth · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2007 · GM
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$388,908Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Protective role of Clec7a/dectin-1 in CNS autoimmunity
$388,891Mari L. Shinohara · Duke University · R01 · FY2024 · NS
Novel mechanism of chemokine nitration in bladder cancer
$388,767Neelam Mukherjee · University Of Texas Hlth Science Center · R01 · FY2025 · CA
Nanoformulated small molecule immunotherapy for SHH medulloblastoma
$388,750Marina Sokolsky-Papkov · Univ Of North Carolina Chapel Hill · R01 · FY2022 · NS
Nanoformulated small molecule immunotherapy for SHH medulloblastoma
$388,750Marina Sokolsky-Papkov · Univ Of North Carolina Chapel Hill · R01 · FY2023 · NS
Project 2
$388,732David A Barbie · Dana-Farber Cancer Inst · P50 · FY2024 · CA
Statistical Methods for Identification and Evaluation of Predictive Biomarkers in Cancer
$388,673Li Chen · University Of Kentucky · R21 · FY2024 · CA
PPARy, TLR Signaling and Atherosclerosis
$388,601Christopher K Glass · University Of California, San Diego · P01 · FY2012 · HL
Role of Ly6K in TGF-beta and immune escape pathways of triple negative breast cancer
$388,498Geeta Upadhyay · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2022 · CA
Core C: Patient Derived Xenograft (PDX)/ Syngeneic Mouse Core
$388,439Gatien Moriceau · University Of California Los Angeles · P01 · FY2021 · CA
Core C: Patient Derived Xenograft (PDX)/ Syngeneic Mouse Core
$388,439Gatien Moriceau · University Of California Los Angeles · P01 · FY2020 · CA
Role of type 2 immune response in pancreatic cancer tumorigenesis
$388,432Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Regulation of T cell activation and exhaustion by Tim-3
$388,425Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
Regulation of T cell activation and exhaustion by Tim-3
$388,425Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI
Regulation of T cell activation and exhaustion by Tim-3
$388,425Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI
Regulation of T cell activation and exhaustion by Tim-3
$388,425Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
Comprehensive Assessment of Cancer Immunotherapy Response
$388,323Timothy Perk · Aiq Solutions, Inc. · R43 · FY2020 · CA
Reprogramming myeloid cells to inhibit cancer development
$388,283Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2022 · CA
The role of the CD58:CD2 axis in cancer immune evasion and resistance to immunotherapy
$388,273Benjamin Izar · Columbia University Health Sciences · R01 · FY2024 · CA